INC Research appoints James Taylor as vice president of clinical development
INC Research, a therapeutically focused global CRO, has appointed James Taylor as vice president of clinical development.
Taylor has more than 25 years of experience in the life sciences industry, including 15 years overseeing and executing global clinical trials. He also brings significant functional expertise in CRO selection and start-up, investigative site performance and contracting, CRO oversight and risk management, and alliance management.
Taylor joins INC Research from Pfizer, where he served most recently as vice president of global clinical trial management. In his new role, he will serve as the primary liaison to biopharmaceutical customers, vendors and investigative sites for the INC Research’s general medicine business unit. Taylor also served as global head of outsourcing management at Sanofi-Aventis, where he was responsible for driving the global outsourcing strategy for its drug innovation and approval business unit.